Compounds > 3-deazaneplanocin
Page last updated: 2024-08-25

3-deazaneplanocin and Chondrosarcoma

3-deazaneplanocin has been researched along with Chondrosarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adouane, D; Aury-Landas, J; Baugé, C; Boumediene, K; Delépée, R; Girard, N; Lhuissier, E1
Bauge, C; Bazille, C; Benateau, H; Boumediene, K; Girard, N; Lhuissier, E; Llombart-Bosch, A1

Other Studies

2 other study(ies) available for 3-deazaneplanocin and Chondrosarcoma

ArticleYear
The Antitumoral Effect of the S-Adenosylhomocysteine Hydrolase Inhibitor, 3-Deazaneplanocin A, is Independent of EZH2 but is Correlated with EGFR Downregulation in Chondrosarcomas.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2019, Volume: 53, Issue:4

    Topics: Adenosine; Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Chondrosarcoma; DNA Damage; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; ErbB Receptors; Histones; Humans; Male; Mice; Mice, Nude; Protein Interaction Maps; RNA Interference; RNA, Small Interfering; S-Adenosylhomocysteine

2019
3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Adenosine; Apoptosis; Cell Line, Tumor; Cell Movement; Chondrosarcoma; Enzyme Inhibitors; Flow Cytometry; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Reverse Transcriptase Polymerase Chain Reaction

2014